Ngā Utu o ngā GLP-1 i te tau 2026: Ngā Utu, Te Tāwharotanga, me ngā Tiaki

Mehemea kei te whakaaro koe ki te rongoā GLP-1 mō te whakaheke taumaha engari i ruarua koe nā te utu, kei te rereke te tau 2026 i te kotahi tau, e rua rānei ki muri.

Kua wātea mai ētahi rongoā waitohu GLP-1 mā ngā hōtaka utu-a-kaihanga i raro iho te utu moni whakaputa i te wā o mua. Kua uru mai anō hoki ngā kōwhiringa ā-waha ki te maakete, ka hoatu ki ngā tūroro etahi atu kōwhiringa i ngā utu rerekē. He rerekē tonu te tāwharotanga inihua, engari kei te huri ngā hōtaka hou a Medicare me ngā hōtaka tiaki a te kaihanga i te utu a ētahi tūroro.

Anei ngā utu o ngā rongoā GLP-1 i te tau 2026, ngā mea kei te huri, me ngā mea hei tirotiro i mua i te whakaaro ka utua e koe te utu moni katoa.

TL;DR: Ngā Take Matua

• Kua wātea ētahi rongoā GLP-1 kua whakaaetia e te FDA mā ngā hōtaka utu-a-kaihanga i te utu whakaputa iti ake i ngā utu moni tikanga.
• Ko te Wegovy (papa) he $149 ia marama mō te 1.5 mg, $199 mō te 4 mg, me te $299 mō te 9 mg me te 25 mg mā roto i te hōtaka utu-a-kaihanga a NovoCare.
• Kua taea e ngā tūroro hou o te werohanga Wegovy te utu $199 ia marama mō ā rātou rua marama tuatahi o te 0.25 mg, 0.5 mg rānei, tae atu ki te 31 o Hakihea 2026. Ko te utu utu-a-kaihanga tikanga, kātahi ka $349 ia marama mō ngā inenga werohanga kua whakarārangitia. Ko te Wegovy HD he $399 ia marama.
• Ko te Foundayo (orforglipron) he utu utu-a-kaihanga ka tīmata i te $149 ia marama mō ētahi inenga. Ko ngā inenga teitei ake he utu rerekē, ā, ka pā te tika ki ngā whakaritenga.
• Ko te Medicare GLP-1 Bridge ka hoatu ki ngā kaipupuri Medicare Part D tika te uru ki ētahi rongoā GLP-1 mō te whakahaere taumaha i te utu $50 ia marama. Ka rere te hōtaka rangitahi mai i te 1 o Hūrae 2026, tae atu ki te 31 o Hakihea 2027.
• Ko te semaglutide kua konatunatua ehara i te mea kua whakaaetia e te FDA. Kua whakaatu te FDA i ngā āwangawanga mō ngā he inenga, ngā hua tinihanga, ngā raruraru kounga, me ngā mahi kino e pā ana ki ētahi hua GLP-1 kua konatunatua.
• He rerekē te tāwharotanga inihua motuhake i ia mahere, te take, ngā whakaritenga whakamana i mua, me te mea kua whakaurua te rongoā whakaheke taumaha ki roto i te painga.
• Ko te utu e utua e koe ka whakawhirinaki ki te rongoā, te inenga, te inihua, ngā hōtaka a te kaihanga, me te mea ka uru koe ki tētahi tuku motuhake.

Kei a koe ngā pātai mō ngā rongoā GLP-1, te utu, te tāwharotanga rānei? Whakaaetia tētahi toro atu ki te $39 i te ipurangi me August AI. Ka taea e tētahi rata whai raihana o te US te tirotiro i tō hītori hauora me te kōrero mena he tika te rongoā GLP-1 mōu, me te rongoā mai i te rongoā i taua rā puta noa i ngā whenua 50 katoa ka tika ana te kiritona.

Ehara te toro atu i te kupu whakaari rongoā. Ko te whakahaere taumaha GLP-1 roa te tikanga ka pai ake te whakahaere e tō rata matua, e tētahi endocrinologist rānei ka taea te tirotiro i te ahunga whakamua, te whakarereke i ngā inenga, me te whakarite i ētahi atu tiaki. Kāore te toro atu ki te ipurangi a August e hoatu rongoā kua konatunatua, kāore rānei i te whakaaetia e te FDA ngā hua GLP-1.

E hia te utu o ngā rongoā GLP-1 i te tau 2026?

Te whakautu poto: he iti ake te utu o ētahi i te wā o mua, engari ka taea tonu e ngā rongoā GLP-1 te utu nui.

Kua whakarewahia e ngā kaihanga ngā hōtaka utu-a-kaihanga tika-ki-te-kaihoko me ngā utu whakaputa mō ētahi hua me ngā inenga. Kua tāpirihia anō e ngā rongoā ā-waha hou ngā kōwhiringa atu ki te maakete.

Ko te utu e utua e koe ka whakawhirinaki ki te rongoā, te inenga, te tāwharotanga inihua, ngā hōtaka tiaki, me te mea ka uru koe ki tētahi tuku a te kaihanga.

Anei ētahi utu utu-a-kaihanga kua whakaputaina mō ngā rongoā waitohu GLP-1 i te tau 2026:

Koinei ngā utu me ngā tuku whakaputa a te kaihanga, ehara i te mea ko te nui e utua e ia tūroro. Ko ngā herenga tika, te inenga, te tūnga inihua, ngā hōtaka tiaki, ngā tāreke, me ngā whakaritenga rongoā ka pā ki te utu whakamutunga.

Utu papa Wegovy ki te utu werohanga Wegovy i te tau 2026

Ko te utu papa Wegovy tetahi o ngā huringa utu nui hei mataki i te tau 2026. Kua whakarārangitia e te hōtaka utu-a-kaihanga a Novo Nordisk ngā utu rerekē i runga i te inenga o te papa.

Ko te utu papa Wegovy o nāianei kua whakaputaina:

Ko te 1.5 mg te inenga tīmata. Ka piki ake ngā papa Wegovy i te wā, ā, ko te inenga tiaki kua whakaaetia e te FDA mō te whakaheke taumaha i ngā pakeke ko te 25 mg kotahi ia rā. Ko te tikanga, ko te $149 te utu tīmata ehara i te utu tonu mō te katoa e tango ana i te papa.

He rerekē te tikanga utu mō te werohanga. Kua taea e ngā tūroro hou tika te utu $199 ia marama mō ā rātou rua marama tuatahi o te 0.25 mg, 0.5 mg rānei, tae atu ki te 31 o Hakihea 2026. Ko te utu utu-a-kaihanga tikanga he $349 ia marama mō ngā inenga werohanga Wegovy kua whakarārangitia, ko te Wegovy HD 7.2 mg he $399 ia marama.

Na, ka whakatairite ana koe i te utu papa Wegovy ki te utu werohanga, kaua e whakatairite i te $149 te utu papa tīmata ki te $349 te utu werohanga me te whakaaro koinei ō utu roa. Ko te inenga, te wā o te rongoā, me te tika ki ngā tuku rangitahi ka pā katoa.

Mō te whakatairite katoa o ngā kōwhiringa ā-waha me ngā werohanga, tirohia tā mātou aratohu mō ngā papa GLP-1 ki ngā werohanga: te utu, ngā hua, me ngā whakatairanga.

He aha ngā utu GLP-1 e huri ana i te tau 2026?

Kāore he take kotahi e huri ai ngā utu GLP-1. He maha ngā whanaketanga kei te tū hei taua wā.

Nui ake te whakataetae

Kāore ko Wegovy me Zepbound anake ngā kōwhiringa matua o te rongoā mō te whakahaere taumaha. Kua tāpirihia e ngā hua ā-waha hou pēnei i a Foundayo me ngā papa Wegovy ētahi atu kōwhiringa, ka hoatu ki ngā kaihanga tētahi atu ara ki te whakataetae mō ngā tūroro e utu ana i te moni.

Ngā hōtaka rongoā tika-ki-te-kaihoko

Kua whakarewahia e Novo Nordisk me Eli Lilly ngā hōtaka utu-a-kaihanga e whakaputa ana i ngā utu moni motuhake mō ngā tūroro tika. Ka hoatu e ēnei hōtaka ki ngā tūroro tētahi atu ara ki te hoko ētahi rongoā i waho atu o ā rātou painga inihua.

Ngā kōwhiringa ā-waha hou

Kua tāpirihia e ngā rongoā GLP-1 ā-waha tetahi wāhanga o te maakete. Ka hoatu e Foundayo me ngā papa Wegovy ngā kōwhiringa ki ngā tūroro i tua atu i ngā werohanga ia wiki, me ngā utu utu-a-kaihanga whakaputa ka rerekē i ia inenga.

Ngā huringa i te tāwharotanga me te uru

Kei te huri anō te tāwharotanga i ētahi wāhi. I tīmata te Medicare GLP-1 Bridge i te 1 o Hūrae 2026, ā, ka hoatu ki ngā kaipupuri Medicare Part D tika te uru ki ētahi rongoā GLP-1 mō te whakahaere taumaha i te utu $50 ia marama. Ka rere te hōtaka i waho o te painga tikanga a Medicare Part D, ā, ka rere tae atu ki te 31 o Hakihea 2027.

Ehara i te mea kua iti te utu o ia GLP-1, kua tāwhirohia rānei e ia mahere inihua. Ko te tikanga kua uru atu ētahi tūroro ki ētahi ara atu ki te tiki ētahi rongoā i te utu iti ake.

Tāwharotanga Medicare mō ngā GLP-1 i te tau 2026

Kua huri te uru a Medicare ki ngā rongoā GLP-1 i te tau 2026 me te whakarewatanga o te Medicare GLP-1 Bridge rangitahi.

Te Medicare GLP-1 Bridge

Mai i te 1 o Hūrae 2026, i tīmata a CMS i te Medicare GLP-1 Bridge, he whakaaturanga poto e rere ana tae noa ki te 31 o Hakihea 2027. Ka taea e ngā kaipupuri Medicare Part D tika te tiki ētahi rongoā GLP-1 mō te whakahaere taumaha i te utu $50 ia marama. Ka rere te hōtaka i waho o te rere o te utu me te tāwharotanga tikanga a Medicare Part D. Ka whakamārama a CMS i te hōtaka me āna whakaritenga tika ki konei.

Ko ngā hua tika o nāianei ko Foundayo, ngā werohanga me ngā papa Wegovy, me te KwikPen o Zepbound ka whakamahia hei whakaheke i te taumaha nui, hei pupuri rānei i te whakaheke taumaha.

Ka pā te tika me ngā whakaritenga whakamana i mua. Ko te tikanga ka hiahiatia e CMS ngā kaipupuri kia tutuki ki ngā paearu kiritona motuhake, tae atu ki te pakeke, te BMI, me ētahi āhuatanga hauora, i te wā i tīmata ai te rongoā GLP-1.

Ko te $50 te utu ka whakahaeretia i waho o te rere o te utu tikanga a Medicare Part D. Kāore te tango i te utu tau tuatahi a Part D e pā, ā, ko te $50 te utu ehara i te mea ka tata ki te TrOOP.

Tētahi atu tāwharotanga a Medicare

I waho atu o te GLP-1 Bridge, ka whakawhirinaki te tāwharotanga a Medicare ki te take kua whakaaetia o te rongoā me te painga Medicare e pā ana. Kua tāwhirohia ētahi rongoā GLP-1 mā te Part D ka tohua mō ngā take kua tāwhirohia pēnei i te mate huka momo 2. Kua whakaaetia hoki e Wegovy te whakarea hei whakaheke i te mate o ētahi mahi kino ki te ngākau i roto i ngā pakeke kua mau te mate ngākau me te taumaha, te mōrearea rānei.

Mehemea kei a koe a Medicare ka whakaaro ki tētahi GLP-1, tirohia te ara tāwharotanga e pā ana ki tō rongoā me te mea ka tutuki koe ki ngā whakaritenga tika o te hōtaka.

Tāwharotanga Inihua mō ngā GLP-1

He nui tonu te rereketanga o te tāwharotanga inihua motuhake.

Ngā mahere kua tautokona e te kaituku mahi

Ka whakawhirinaki te tāwharotanga ki te mahere motuhake. Ko ētahi mahere kaituku mahi e tāwhiro ana i ngā GLP-1 mō te whakahaere taumaha, ko ētahi atu ka whakakore i ngā rongoā whakaheke taumaha. Kua hiahiatia pea he whakamana i mua.

Ngā mahere takitahi me ngā maakete

Ka rerekē te tāwharotanga i ia kaiinihua, i ia whenua, me i ia mahere. Ko te mea kua whakaaetia e te rongoā e te FDA mō te whakahaere taumaha kāore e tikanga ana ka tāwhirohia e ia mahere maakete.

Whakamana i mua

Ahakoa kua whai tāwharotanga, ka hiahia pea ngā kaiinihua kia whakamana i mua. Ka taea te whakauru i ngā paearu BMI motuhake, ētahi āhuatanga hauora, te tiaki i ngā rongoā o mua, me ētahi atu paearu i whakatakotohia e te mahere.

Te rongoā takahuri

Ka hiahiatia e ētahi mahere kia ngana ngā mema ki ētahi atu rongoā i mua i te whakaaetanga o tētahi GLP-1. Ka rerekē ēnei whakaritenga i ia kaiinihua me i ia mahere.

Mehemea ka tāwhirohia e tō mahere tētahi GLP-1, ka taea e tētahi hōtaka tiaki a te kaihanga te whakaheke i tō utu ki waho o te pukoro mehemea ka tika koe. Hei tauira, kei te panui a NovoCare i ēnei wā te tiaki inihua arumoni kia iti iho i te $25 ia marama mō ngā tūroro tika. Ko ngā kaipupuri kāwanatanga ka whakakorehia i tērā tuku motuhake.

Kei te haumaru, kei te iti ake te utu o te semaglutide kua konatunatua?

Ka taea e te semaglutide kua konatunatua te iti ake te utu i ētahi kōwhiringa waitohu, koinei tētahi take e rapuhia ai e te iwi. Engari ko te utu anake kāore e kī ana mena he tika te rongoā kua konatunatua mō koe.

Ko te semaglutide kua konatunatua ehara i te mea rite ki a Wegovy kua whakaaetia e te FDA, ki ētahi atu hua semaglutide kua whakaaetia e te FDA. Kāore ngā rongoā kua konatunatua e haere i roto i te arokengōaro a te FDA mō te haumaru, te whai hua, me te kounga ka haere ngā rongoā kua whakaaetia.

Kua whakaatu te FDA i ngā āwangawanga mō ētahi hua GLP-1 kua konatunatua, tae atu ki:

• Ngā he inenga e pā ana ki te semaglutide werohanga kua konatunatua
• Ngā mahi kino, tae atu ki ngā pūrongo e pā ana ki te whakarongo ki te hōhipera
• Ngā hua tinihanga e mau ana i ngā mōhiohio rongoā teka
• Ngā āwangawanga mō ētahi momo tote semaglutide e whakamahia ana i roto i ngā hua
• Ngā hua kua hokona kāore he rongoā tika, mā ngā puna rangirua rānei

I te 31 o Mei 2026, kua whiwhi te FDA i ngā pūrongo mahi kino 990 e pā ana ki te semaglutide kua konatunatua. E kī ana te kāwanatanga ka taea te iti noa te ripoata o ngā mahi kino, ā, ehara i te mea ka whakamārama te pūrongo mahi kino kua puta te rongoā te take.

Ka taea te hanga rongoā kua konatunatua i raro i ētahi tikanga. Ka tūtohu te FDA kia whakamahia ngā rongoā kua konatunatua ka kore e tutuki ngā hiahia hauora o te tūroro e tētahi rongoā kua whakaaetia e te FDA. Ko ngā tūroro e whakaaro ana ki tētahi rongoā kua konatunatua me kōrero ki tō rata ka tiki mai i tētahi rongoā whai raihana tika.

Mehemea kei te whakaaro koe ki te semaglutide kua konatunatua nā te utu, pātai atu ki tō rata mō ngā kōwhiringa kua whakaaetia e te FDA me ngā hōtaka utu-a-kaihanga o nāianei i mua i te whakatau he aha te kōwhiringa e tika ana ki tō āhua.

Me pēhea te utu iti ake mō ngā rongoā GLP-1

Mehemea kei te utu koe i te moni, whakatairitea te utu tūturu o te rongoā kaua e aro noa ki te utu iti rawa kua panuitia.

Whakamahia ngā hōtaka utu-a-kaihanga

Ka whakaputa ngā hōtaka tika-ki-te-kaihoko a NovoCare me Lilly i ngā utu moni mō ngā tūroro tika. Whakatairitea ngā utu nei ki te nui e utua e koe mā te inihua, mā tō rongoā tātahi rānei.

Tirohia ngā hōtaka tiaki a te kaihanga

Mehemea kua whai inihua arumoni koe, ka taea e koe te uru ki tētahi hōtaka tiaki a te kaihanga. Ka rerekē te tika, ā, ko ngā kaipupuri Medicare me Medicaid ka whakakorehia i ngā tuku kāri tiaki arumoni.

Tirohia ngā hōtaka āwhina tūroro

Kua tukua e ētahi kaihanga ngā hōtaka āwhina tūroro mō ngā tāngata e tutuki ana ki ngā whakaritenga tika me ngā tikanga moni. Tirohia ngā tikanga hōtaka o nāianei tika ki te kaihanga.

Tirohia te tāwharotanga Medicaid

Ka rerekē te tāwharotanga Medicaid i ia whenua me te take i tohua ai te rongoā. Tirohia te hōtaka Medicaid o tō whenua me tō mahere motuhake kaua e whakaaro kua wātea te tāwharotanga, kua whakakorea rānei.

Whakatairitea te utu katoa ia marama

Kaua e whakatairite rongoā i runga noa i te utu tīmata kua panuitia. Ko te utu tīmata iti ake ka pā pea ki ētahi inenga, ki tētahi maha rānei o ngā whakakii. Tirohia te utu o te inenga ka tohua ki a koe, me ētahi atu utu tohutohu, rongoā, me te inihua.

Ngā Pātai Auau

E hia te utu o Wegovy ia marama i te tau 2026?

Ko te utu utu-a-kaihanga papa Wegovy he $149 ia marama mō te 1.5 mg, $199 mō te 4 mg, me te $299 mō te 9 mg me te 25 mg. Mō te werohanga Wegovy, kua taea e ngā tūroro hou tika te utu $199 ia marama mō ā rātou rua marama tuatahi o te 0.25 mg, 0.5 mg rānei, tae atu ki te 31 o Hakihea 2026. Ko te utu utu-a-kaihanga tikanga he $349 ia marama mō ngā inenga werohanga kua whakarārangitia, ko te Wegovy HD he $399 ia marama.

Ka tāwhirohia e Medicare a Wegovy mō te whakaheke taumaha?

I te tau 2026, ka taea e ngā kaipupuri Medicare Part D tika te uru ki a Wegovy me ētahi atu rongoā GLP-1 mō te whakahaere taumaha mā te Medicare GLP-1 Bridge. I tīmata te hōtaka i te 1 o Hūrae 2026, ka rere tae noa ki te 31 o Hakihea 2027, ā, he $50 te utu ia marama mō ngā kaipupuri tika. Ka pā te tika me ngā whakaritenga whakamana i mua.

Kua whakaaetia e te FDA te semaglutide kua konatunatua?

Kāore. Ko te semaglutide kua konatunatua ehara i te mea kua whakaaetia e te FDA. Kua whakaatu te FDA i ngā āwangawanga mō ētahi hua GLP-1 kua konatunatua, tae atu ki ngā he inenga, ngā hua tinihanga, me ngā raruraru kounga.

E hia te utu o Foundayo?

Ka tīmata te utu utu-a-kaihanga Foundayo i te $149 ia marama mō ētahi inenga. Ko ētahi atu inenga he utu whakaputa teitei ake, ā, ko ētahi inenga ka whai utu whakatairanga rangitahi. Ka pā te tika me ngā herenga hōtaka.

Ka taea e au te whakamahi i te inihua me te kāri tiaki a te kaihanga tahi?

Mehemea kua whai inihua arumoni koe, ka taea e koe te whakamahi i tētahi hōtaka tiaki a te kaihanga i muri i te tukunga o tō inihua i te kerēme, i runga i te hōtaka motuhake. Ko ngā kaipupuri kāwanatanga ka whakakorehia i ngā tuku tiaki arumoni. Tirohia ngā tikanga o nāianei mō te rongoā kua tohua ki a koe.

Ka mau tonu te heke o ngā utu GLP-1?

Kāore i te kupu whakaari te utu ā muri. Ko te whakataetae, ngā hua hou, ngā hōtaka utu-a-kaihanga, ngā huringa tāwharotanga inihua, me ngā whakaaetanga ā muri ka pā ki te utu a ngā tūroro. Mehemea kei te whakatairite koe i ngā utu, tirohia ngā tikanga kaihanga me te inihua o nāianei kaua e whakawhirinaki ki tētahi utu moni tawhito.

Whakautu

Kua huri te utu GLP-1 i te tau 2026, otirā mō ngā tāngata e tika ana ki ngā hōtaka utu-a-kaihanga. Ka tīmata ngā papa Wegovy i te $149 ia marama, ko Foundayo he utu utu-a-kaihanga ka tīmata i te $149 mō ētahi inenga, ā, kua taea e ngā tūroro hou tika o te werohanga Wegovy te utu $199 mō ā rātou rua marama tuatahi o ētahi inenga tīmata.

Kua huri anō te uru a Medicare. Ko te Medicare GLP-1 Bridge ka hoatu ki ngā kaipupuri Part D tika te uru ki ētahi rongoā GLP-1 whakahaere taumaha mō te $50 ia marama tae atu ki te 31 o Hakihea 2027.

He nui tonu te rereketanga o te inihua motuhake. Ko te whakamana i mua, ko te whakakore i te mahere, ko ngā utu tau tuatahi, me te tika ki te hōtaka tiaki ka taea te huri i tō utu whakamutunga.

Ka taea e te semaglutide kua konatunatua te iti ake te utu kua panuitia, engari ehara i te mea kua whakaaetia e te FDA, ā, kua whakaatu te FDA i ngā āwangawanga mō ngā he inenga, ngā hua tinihanga, me ngā raruraru kounga e pā ana ki ētahi hua GLP-1 kua konatunatua.

Mehemea kei te whakaaro koe ki tētahi GLP-1, whakatairitea te utu tūturu o te inenga kua tohua ki a koe kaua e te utu tīmata iti rawa kua panuitia. Pātai atu ki tō rata me tō kaiinihua mō te tāwharotanga, ngā hōtaka kaihanga, me te utu katoa ia marama i mua i te whakatau he aha te kōwhiringa e tika ana ki tō āhua.